APR 17, 2019 5:23 PM PDT

Using Engineered Bacteria to Rapidly Evaluate Therapeutics

WRITTEN BY: Carmen Leitch

Scientists are using genetic tools to engineer bacteria in many ways. These new microbes are able to mimic or sense disease states, so that researchers can use them to study illness, like infectious pathogens or cancer. These genetic techniques that program bacterial cell behavior can also be used to create circuits that not only act as sensors but are also responders, for example, creating therapeutic molecules in certain situations. These engineered microbes can also be used to test treatments or act as delivery systems, like a kind of living medicine. 

Now, scientists from Columbia Engineering report a method for using programmed bacteria as a kind of miniaturized tissue that can model tumors. The technique, called "bacteria spheroids co-culture," or BSCC, has been reported in the Proceedings of the National Academy of Sciences (PNAS); it is a high-speed method for rapidly evaluating therapeutics.

The image shows engineered bacteria (green) in tumor spheroids cultured in a multi-well plate. / Credit: Tetsuhiro Harimoto/Columbia Engineering

"We're very excited at how efficient BSCC is and think it will really accelerate engineered bacterial therapy for clinical use," said the research leader Tal Danino, an assistant professor of biomedical engineering. "By combining automation and robotics technology, BSCC can test a large library of therapies to discover effective treatments. And because BSCC is so broadly applicable, we can modify the system to test human samples as well as other diseases. For example, it will help us personalize medical treatments by creating a patient's cancer in a dish, and rapidly identify the best therapy for the specific individual."

The microenvironment of a tumor impairs the local immune response, and bacteria that would be killed if it was elsewhere in the body is able to grow in the tumor. The researchers used that knowledge; they used an antimicrobial agent, an antibiotic called gentamicin, and cultured bacteria in spheroids, mimicking tumors in the body. With the BSCC technique, they were able to quickly assess many different programmed anticancer bacterial therapies like genetic circuits or engineered microbes.

Bacteria colonize multicellular spheroids in vitro where they are screened for growth, circuit dynamics, and therapeutic efficacy and then are validated in mouse tumor models. / Credit: Tetsuhiro Harimoto/Columbia Engineering

"We used 3D multicellular spheroids because they recapitulate conditions found in the human body, such as oxygen and nutrient gradients; these can't be made in a traditional 2D monolayer cell culture," said the lead author of the report Tetsuhiro Harimoto, a graduate candidate working in Danino's lab. "In addition, the 3D spheroid provides bacteria with enough space to live in its core, in much the same way that bacteria colonize tumors in the body, also something we can't do in the 2D monolayer culture. Plus, it's simple to make large numbers of 3D spheroids and adapt them for high-throughput screening."

The team was able to use BSCC as a high-throughput way to characterize batches of programmed bacteria and identify those that show the most promise. They found a novel bacterial toxin called theta toxin, which has significant impacts on colon cancer when combined with a delivery circuit that uses attenuated Salmonella Typhimurium. Anticancer therapeutic efficacy was also improved by some bacterial therapeutics they tested.

The scientists are hopeful that this work will have additional applications. They would like to use BSCC for microbial therapeutics that apply to other diseases, like infectious illnesses and gastrointestinal disorders. 

Sources: AAAS/Eurekalert! via Columbia University School of Engineering and Applied Science, PNAS

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 16, 2021
Coronavirus
Focusing on the Cause of Neurological Symptoms of COVID-19
JUL 16, 2021
Focusing on the Cause of Neurological Symptoms of COVID-19
We now know that COVID-19 can cause a range of symptoms. Some of these problems are taking months to clear up in patient ...
JUL 22, 2021
Immunology
"Stunning" Anti-Inflammatory Effects of a Fermented Food Diet
JUL 22, 2021
"Stunning" Anti-Inflammatory Effects of a Fermented Food Diet
Researchers at Stanford University have found that consuming fermented foods such as yogurt, sauerkraut, and kombucha te ...
JUL 18, 2021
Genetics & Genomics
Researchers Find Strange 'Borg' DNA - It's Assimilating
JUL 18, 2021
Researchers Find Strange 'Borg' DNA - It's Assimilating
Our environment is full of DNA molecules. While researchers have become concerned about DNA waste material that's ac ...
JUL 30, 2021
Microbiology
Viruses Captured at High Resolution as They Moved in 3D
JUL 30, 2021
Viruses Captured at High Resolution as They Moved in 3D
Scientists have used powerful tools to get a better look at viruses at they move through liquid. A new study that was re ...
AUG 15, 2021
Coronavirus
A COVID-19 Vaccine Booster Now Recommended for Immunocompromised People
AUG 15, 2021
A COVID-19 Vaccine Booster Now Recommended for Immunocompromised People
As Delta has become the dominant SARS-CoV-2 variant causing COVID-19 infections in the United States, researchers and he ...
SEP 06, 2021
Microbiology
Imbokodo Trial Shows HIV Vaccine Candidate Isn't Effective Enough
SEP 06, 2021
Imbokodo Trial Shows HIV Vaccine Candidate Isn't Effective Enough
HIV vaccines have remained elusive in part because the virus has a powerful ability to mutate, and there are so many str ...
Loading Comments...